| # | Name | Price | 24h % | 7d % | Market Cap | Volume (24h) | Last 7 Days |
|---|---|---|---|---|---|---|---|
| 1501 | NT$30.30 | +2.02% | -14.09% | NT$1.5B $46.45M · €40.48M | 259.95K shrs NT$7.88M | ||
| 1502 | A$0.05 | -4.00% | +7.69% | A$70.74M $45.98M · €40.08M | 25.68M shrs A$1.23M | ||
| 1503 | ₩4880.00 | +1.14% | +3.64% | ₩63.76B $45.91M · €40.01M | 32.49K shrs ₩158.57M | ||
| 1504 | ₹46.03 | +0.44% | -6.73% | ₹3.82B $45.84M · €39.95M | 52.62K shrs ₹2.42M | ||
| 1505 | ¥677.00 | +4.64% | +4.51% | ¥6.82B $45.68M · €39.81M | 16.1K shrs ¥10.9M | ||
| 1506 | ₹45.52 | -0.85% | -6.75% | ₹3.78B $45.33M · €39.51M | 298.81K shrs ₹13.6M | ||
| 1507 | ¥340.00 | +3.66% | +10.00% | ¥6.74B $45.16M · €39.37M | 79.4K shrs ¥27M | ||
| 1508 | A$0.28 | +0.00% | +0.00% | A$69.38M $45.10M · €39.31M | 59.5K shrs A$16.96K | ||
| 1509 | ₩3820.00 | +2.14% | -0.53% | ₩61.82B $44.51M · €38.79M | 265.53K shrs ₩1.01B | ||
| 1510 | NT$16.50 | -0.30% | -2.15% | NT$1.42B $43.99M · €38.35M | 34.89K shrs NT$575.67K | ||
| 1511 | C$0.86 | +6.17% | +2.04% | C$59.24M $43.84M · €38.21M | 10.69K shrs C$9.19K | ||
| 1512 | ₪0.03 | -3.05% | +6.44% | ₪161.91M $43.72M · €38.10M | 4.12K shrs ₪12.21K | ||
| 1513 | NT$19.90 | +14.04% | -4.50% | NT$1.41B $43.61M · €38.01M | 796.73K shrs NT$15.85M | ||
| 1514 | C$2.20 | -10.20% | -3.27% | C$58.47M $43.27M · €37.71M | 22.1K shrs C$48.62K | ||
| 1515 | ¥246.00 | +0.00% | -15.23% | ¥6.43B $43.11M · €37.58M | 32.4K shrs ¥7.97M | ||
| 1516 | ₩5170.00 | +0.00% | +4.20% | ₩59.76B $43.03M · €37.50M | 18.78K shrs ₩97.08M | ||
| 1517 | ₩7090.00 | +4.42% | +13.22% | ₩59.62B $42.92M · €37.41M | 58.09K shrs ₩411.86M | ||
| 1518 | NT$18.55 | +0.27% | -0.56% | NT$1.38B $42.88M · €37.38M | 115.68K shrs NT$2.15M | ||
| 1519 | RM 0.65 | +2.38% | -2.70% | RM 193.01M $42.46M · €37.01M | 242.8K shrs RM 156.61K | ||
| 1520 | C$1.65 | -4.62% | -2.23% | C$56.91M $42.12M · €36.71M | 6.34K shrs C$10.46K | ||
| 1521 | ¥23.00 | +4.55% | +13.04% | ¥6.28B $42.07M · €36.67M | 11.28M shrs ¥259.54M | ||
| 1522 | NT$34.00 | +1.80% | -2.90% | NT$1.35B $41.86M · €36.49M | 7K shrs NT$238K | ||
| 1523 | NT$16.85 | -0.88% | +0.65% | NT$1.35B $41.79M · €36.42M | 204.39K shrs NT$3.44M | ||
| 1524 | £23.50 | +0.00% | -8.70% | £32.56M $41.35M · €36.04M | 220.25K shrs £5.18M | ||
| 1525 | NT$11.00 | -5.98% | -2.62% | NT$1.32B $40.78M · €35.54M | 928.42K shrs NT$10.21M | ||
| 1526 | ฿5.70 | -0.87% | -0.89% | ฿1.45B $40.60M · €35.38M | 76.42K shrs ฿435.58K | ||
| 1527 | ₩6140.00 | +1.32% | -33.37% | ₩56.31B $40.54M · €35.34M | 88.98K shrs ₩546.36M | ||
| 1528 | ₩487.00 | -1.81% | -14.17% | ₩56.22B $40.48M · €35.28M | 88.34K shrs ₩43.02M | ||
| 1529 | NT$21.35 | -1.16% | +0.49% | NT$1.29B $40.08M · €34.93M | 354.42K shrs NT$7.57M | ||
| 1530 | A$0.12 | +0.00% | +20.00% | A$61.6M $40.04M · €34.90M | 947.85K shrs A$113.74K | ||
| 1531 | ₹245.65 | -3.93% | +15.18% | ₹3.33B $39.98M · €34.85M | 46.66K shrs ₹11.46M | ||
| 1532 | ₹245.30 | -3.99% | +15.92% | ₹3.33B $39.92M · €34.80M | 1.74K shrs ₹426.33K | ||
| 1533 | C$0.58 | -1.69% | +0.00% | C$53.39M $39.51M · €34.43M | 15.53K shrs C$9.01K | ||
| 1534 | ₩891.00 | -0.11% | +13.30% | ₩54.39B $39.16M · €34.13M | 134.51K shrs ₩119.85M | ||
| 1535 | ₩3150.00 | +1.12% | +2.15% | ₩54.22B $39.04M · €34.03M | 57.2K shrs ₩180.17M | ||
| 1536 | NT$17.45 | -0.29% | -2.17% | NT$1.26B $39.02M · €34.01M | 38K shrs NT$663.15K | ||
| 1537 | A$0.02 | +0.00% | +10.53% | A$59.85M $38.90M · €33.91M | 10.92M shrs A$240.33K | ||
| 1538 | C$0.15 | -3.23% | -12.50% | C$52.16M $38.60M · €33.64M | 104.86K shrs C$15.73K | ||
| 1539 | ¥500.00 | -0.20% | -8.16% | ¥5.75B $38.53M · €33.59M | 5.3K shrs ¥2.65M | ||
| 1540 | ₩4735.00 | -2.57% | -0.11% | ₩53.03B $38.18M · €33.28M | 11.98K shrs ₩56.73M | ||
| 1541 | NT$30.80 | +0.16% | -2.77% | NT$1.23B $38.11M · €33.21M | 23.22K shrs NT$715.21K | ||
| 1542 | ¥569.00 | +2.52% | +8.01% | ¥5.67B $38.01M · €33.13M | 38K shrs ¥21.62M | ||
| 1543 |  TMS Co., Ltd. 4891.T🇯🇵JPY | ¥124.00 | +3.33% | +7.92% | ¥5.65B $37.86M · €33.00M | 243.2K shrs ¥30.16M | |
| 1544 | ₹71.91 | +5.66% | +9.10% | ₹3.15B $37.79M · €32.94M | 46.34K shrs ₹3.33M | ||
| 1545 | ¥1555.00 | +0.65% | -1.34% | ¥5.64B $37.76M · €32.92M | 600 shrs ¥933K | ||
| 1546 | NT$24.65 | -4.64% | -1.52% | NT$1.21B $37.52M · €32.70M | 46.27K shrs NT$1.14M | ||
| 1547 | ¥128.00 | +0.00% | +6.03% | ¥5.54B $37.14M · €32.37M | 128K shrs ¥16.38M | ||
| 1548 | ₩4170.00 | +0.48% | +2.64% | ₩51.52B $37.09M · €32.33M | 27.37K shrs ₩114.13M | ||
| 1549 | ¥1083.00 | +5.76% | -9.14% | ¥5.54B $37.09M · €32.33M | 8.5K shrs ¥9.21M | ||
| 1550 | BiOptic Inc. 6850.TWO🇹🇼TWD | NT$35.80 | +1.70% | -2.30% | NT$1.18B $36.72M · €32.01M | 1K shrs NT$35.8K | |
| 1551 | ¥75.00 | +5.63% | +2.90% | ¥5.41B $36.25M · €31.60M | 472.2K shrs ¥35.41M | ||
| 1552 | NT$63.40 | -0.16% | -1.33% | NT$1.17B $36.20M · €31.55M | 7.1K shrs NT$450.27K | ||
| 1553 | ¥74.00 | +1.37% | +15.15% | ¥5.37B $36.01M · €31.39M | 577.6K shrs ¥42.74M | ||
| 1554 | ¥145.00 | +2.84% | +6.67% | ¥5.36B $35.91M · €31.30M | 112.7K shrs ¥16.34M | ||
| 1555 | ₩2500.00 | -3.66% | +6.83% | ₩49.82B $35.87M · €31.26M | 121.81K shrs ₩304.53M | ||
| 1556 | NT$24.25 | +0.83% | +0.61% | NT$1.13B $35.02M · €30.52M | 9.43K shrs NT$228.65K | ||
| 1557 | A$0.03 | +0.00% | +6.67% | A$53.85M $35.00M · €30.51M | 430.63K shrs A$14.21K | ||
| 1558 | ₹243.00 | +0.04% | +4.27% | ₹2.9B $34.80M · €30.33M | 34.8K shrs ₹8.46M | ||
| 1559 | NT$29.85 | -0.50% | -4.03% | NT$1.12B $34.62M · €30.17M | 7K shrs NT$208.95K | ||
| 1560 |  ImmuPharma plc IMM.L🇬🇧GBp | £4.33 | -2.26% | -10.85% | £27.02M $34.31M · €29.90M | 1.46M shrs £6.33M | |
| 1561 | NT$34.10 | +1.64% | +0.32% | NT$1.11B $34.31M · €29.90M | 265.94K shrs NT$9.07M | ||
| 1562 | NT$11.40 | -2.56% | +1.30% | NT$1.09B $33.92M · €29.56M | 359.58K shrs NT$4.1M | ||
| 1563 | ₹267.90 | -5.00% | -0.99% | ₹2.82B $33.79M · €29.45M | 7K shrs ₹1.88M | ||
| 1564 | RM 0.69 | +0.00% | +3.88% | RM 153.08M $33.68M · €29.35M | — | ||
| 1565 | ₩1360.00 | -0.95% | +1.46% | ₩46.18B $33.25M · €28.98M | 87.41K shrs ₩118.88M | ||
| 1566 |  Nexsen Ltd NXN.AX🇦🇺AUD | A$0.26 | +13.33% | +17.78% | A$51.05M $33.18M · €28.92M | 585.14K shrs A$149.21K | |
| 1567 | £69.00 | +4.55% | +1.60% | £26.05M $33.09M · €28.84M | 52.15K shrs £3.6M | ||
| 1568 | RP Bio Inc. 314140.KQ🇰🇷KRW | ₩5300.00 | +4.74% | +5.50% | ₩45.84B $33.01M · €28.77M | 65.82K shrs ₩348.86M | |
| 1569 | ₩5170.00 | -3.00% | -2.91% | ₩45.63B $32.86M · €28.64M | 55.8K shrs ₩288.49M | ||
| 1570 | Rp 300.00 | +1.35% | +1.29% | Rp 529.69B $32.84M · €28.62M | 38.1K shrs Rp 11.43M | ||
| 1571 | ₹44.39 | -1.36% | -1.89% | ₹2.71B $32.51M · €28.34M | 1.56K shrs ₹69.38K | ||
| 1572 | ₩1480.00 | -1.66% | +1.69% | ₩45.09B $32.46M · €28.30M | 695.32K shrs ₩1.03B | ||
| 1573 | NT$22.10 | -0.67% | +3.49% | NT$1.05B $32.41M · €28.24M | 96.23K shrs NT$2.13M | ||
| 1574 | NT$21.80 | -3.96% | +1.30% | NT$1.05B $32.40M · €28.24M | 3K shrs NT$65.4K | ||
| 1575 | A$0.01 | +8.33% | +0.00% | A$49.8M $32.37M · €28.21M | 10.81M shrs A$140.53K | ||
| 1576 | ₪0.10 | -1.78% | +2.92% | ₪119.85M $32.36M · €28.21M | 9 shrs ₪94.5 | ||
| 1577 | ¥212.00 | -0.93% | +2.94% | ¥4.79B $32.08M · €27.96M | 20.1K shrs ¥4.26M | ||
| 1578 | NT$18.00 | -0.83% | -1.76% | NT$1.03B $31.97M · €27.87M | 73.44K shrs NT$1.32M | ||
| 1579 | ₹34.47 | -0.98% | +0.66% | ₹2.64B $31.70M · €27.63M | 11.98K shrs ₹412.85K | ||
| 1580 | NT$6.93 | -2.67% | +0.71% | NT$1.01B $31.36M · €27.33M | 62.96K shrs NT$436.31K | ||
| 1581 |  Provexis plc PXS.L🇬🇧GBp | £1.05 | -4.55% | +2.00% | £24.63M $31.28M · €27.27M | 130.97K shrs £137.52K | |
| 1582 |  MedMira Inc. MIR.V🇨🇦CAD | C$0.06 | +9.09% | +0.00% | C$42.1M $31.16M · €27.16M | 123K shrs C$7.38K | |
| 1583 | NT$41.25 | -4.62% | +1.46% | NT$1B $31.14M · €27.14M | 3.16K shrs NT$130.43K | ||
| 1584 | NT$17.90 | +0.56% | -0.89% | NT$1B $31.06M · €27.07M | 46.3K shrs NT$828.84K | ||
| 1585 | NT$23.90 | -0.42% | -3.52% | NT$1B $31.02M · €27.04M | 35.01K shrs NT$836.69K | ||
| 1586 | NT$12.60 | -3.45% | -1.16% | NT$999.56M $30.99M · €27.01M | 33.43K shrs NT$421.23K | ||
| 1587 | ₹10.62 | -2.48% | -2.94% | ₹2.58B $30.96M · €26.99M | 246.83K shrs ₹2.62M | ||
| 1588 | C$0.33 | +0.00% | -1.56% | C$41.82M $30.95M · €26.97M | 65K shrs C$21.45K | ||
| 1589 | A$0.02 | +5.26% | +10.53% | A$47.3M $30.74M · €26.80M | 4.68M shrs A$93.59K | ||
| 1590 | A$0.03 | -3.85% | +0.00% | A$46.92M $30.50M · €26.58M | 5.03M shrs A$125.68K | ||
| 1591 | NT$37.00 | +0.00% | +0.00% | NT$978.97M $30.35M · €26.45M | 20 shrs NT$740 | ||
| 1592 | ₩2465.00 | -2.95% | +6.31% | ₩41.09B $29.59M · €25.79M | 58.1K shrs ₩143.21M | ||
| 1593 | A$0.06 | -1.64% | +16.67% | A$45.24M $29.41M · €25.63M | 975.11K shrs A$58.51K | ||
| 1594 | ₩2650.00 | -0.56% | +2.72% | ₩39.79B $28.65M · €24.97M | 73.88K shrs ₩195.77M | ||
| 1595 | NT$19.05 | +0.26% | -10.84% | NT$920.07M $28.52M · €24.86M | 25.1K shrs NT$478.15K | ||
| 1596 | NT$10.15 | +0.50% | -1.48% | NT$913.5M $28.32M · €24.68M | 167.81K shrs NT$1.7M | ||
| 1597 | NT$51.40 | -0.19% | -0.60% | NT$909.76M $28.20M · €24.58M | 40 shrs NT$2.06K | ||
| 1598 | ₹11.98 | +0.00% | -2.03% | ₹2.33B $27.93M · €24.34M | 196.87K shrs ₹2.36M | ||
| 1599 | ₹11.96 | -0.17% | — | ₹2.32B $27.88M · €24.30M | 9.82K shrs ₹117.44K | ||
| 1600 | A$0.38 | +0.00% | +7.32% | A$42.81M $27.83M · €24.25M | 299.64K shrs A$113.86K |
Browse by Country
Europe
Asia